Requests similar to 'Equity of access for low side-effect formulations for therapeutic treatment of anxiety, depression & ADHD' (page 7)
Management of Stelazine (trifluoperazine) supply
Response by Pharmaceutical Management Agency to WGRH on .
Information not held.
Dear Dr Harrison,
PHARMAC is extending the response date for your request, please see letter attached.
Please let me know if you have any questions o...
Safety Trial Doctors & Ad Agencies
Response by Ministry of Health to Jai Ganesh on .
Information not held.
Kia ora Jai,
Thank you for your request for official information to the Ministry of
Health (the Ministry), on 16 June 2022 for the following: ...
Medicines Act interpretation, ethics oversight, and consent frameworks
Response by Ministry of Health to SPENCER JONES on .
Partially successful.
Kia ora,
Please find attached the response for your request for official
information.
Ngā mihi,
OIA Services Team
M...
Breif given to Sir Peter Gluckman - further information required
Response by Phil Twyford to Jo Kirk on .
Partially successful.
Dear Ms Kirk,
The following portions of your Official Information request entitled
“Brief given to Sir Peter Gluckman - further information requ...
Covid Vaccines Trail information
Response by Ministry of Health to Raff Potter on .
Awaiting classification.
Kia ora Raff
Please find attached a letter regarding your request for information.
Ngā mihi
OIA Services
Government Services
Offi...
Evidence used in determining whether to vaccinate children 5-11
Response by Ministry of Health to Athina Andonatou on .
Long overdue.
Kia ora Athina
Please find attached a letter regarding your request for information.
Ngā mihi
OIA Services
Government Services
Office of the Di...
Discussions, correspondence, minutes etc in 2025 on Covid vaccine use in pregnant women
Response by Ministry of Health to Erika Whittome on .
Successful.
Kia ora Erika,
Please find attached a response to your request for official information.
Ngā mihi,
Government Services | Pharmac
__...
Supporting evidence to debunked misconceptions as published by the Nz Herald in support of the MoH
Response by Ministry of Health to Nastassja Catmull-Gillespie on .
Awaiting classification.
Tçnâ koe Nastassja
Thank you for your request under the Official Information Act 1982 (the
Act) to the Ministry of Health (the Ministry) on...
Review of the Evidence regarding Effectiveness of Ivermectin in Treatment of Covid-19
Response by Ministry of Health to Adrian O'Flynn on .
Awaiting classification.
Kia ora Adrian O’Flynn
Please find attached a letter regarding your request for information.
Ngâ mihi
OIA Services
Gove...
Medsafe Methods of Assessing Covid Vaccines
Response by Ministry of Health to Virginia Crawford on .
Partially successful.
Kia ora Virginia,
On behalf of Chris James, Group Manager, Medsafe, please see attached the response to your OIA request.
Ngā mihi
Yuuki Smithers...
Number of young non-smokers who are now vaping
Response by Ministry of Health to Michael Vaughan on .
Successful.
Hello again
Sorry I didn't attach the information requested to the previous email.
Please find below..
Kind regards
OIA Services
Government Se...
Costs outweigh Benefits of Vaccine - Medsafe Disastrous Approval
Request sent to Ministry of Health by Chuck Schooner (Account suspended) on .
Partially successful.
The Pfizer vaccine has been approved provisionally until 3 November 2021 subject to 58 Conditions by Medsafe.
Can you please confirm all the condi...
28 – For Ministry of Youth Development (MYD) – ADHD and Youth Policy
Response by Ministry of Social Development to Elspeth Baker-Vevers on .
Partially successful.
IN-CONFIDENCE
Kia ora Elspeth Baker-Vevers
Please find attached the Ministry’s response to your Official Information
Act request.
...
Medicinal Cannabis Agency - Information regarding medicinal cannabis prescriptions
Response by Health New Zealand to Mr McDonald on .
Awaiting classification.
Kia ora,
Please find attached a response regarding your request for information.
If you have any questions, please get in touch
at [1][Health...
Supply agreement with Pfizer for supply of Cominarty brand of Covid-19 vaccine
Response by Pharmaceutical Management Agency to John Armstrong on .
Partially successful.
Kia ora John,
Please find attached the response for your request for official
information.
Ngā mihi
OIA Services Team
Ministry of Healt...
Policies and Procedures Relating to Medication‑Induced Nutrient Depletion and Associated Physiological Effects
Response by Health New Zealand to Nigel Gray on .
Awaiting classification.
Tēnā koe Nigel
Your request for official information, reference: HNZ00201245
Thank you for your email on 1 March 2026, asking Health New Zealan...
Tçnâ koe Jai,
Thank you for your request under the Official Information Act 1982 (the
Act) on 28 June 2022 for information relating to prescri...
Information on lessons learned from Military Activity Camps
Response by Oranga Tamariki—Ministry for Children to Ryan Wilkinson on .
Successful.
IN-CONFIDENCE
Kia ora Ryan
Please see attached a response to the second part of your Official
Information Act request of 24 June 2025.
N...
Kia ora R McLeod,
Please find attached a response to your request for information.
Ngā mihi
OIA Services Team
[1]www.health.gov...
Please detail the policy behind Pfizer vaccine exclusivity
Response by Ministry of Health to R McLeod on .
Successful.
Kia ora R McLeod,
Please find attached a response to your request for information.
Ngā mihi
OIA Services Team
[1]www.health.gov...
Risk assessment/ profile for vaccinate vs. unvaccinated in under 40 year olds
Request sent to Ministry of Health by Mrs Denis on .
Awaiting classification.
Could you please provide all related correspondence/reports/technical support information surrounding the determination of the risk profile for peopl...
Change to Graduate-only entry into the MBChB programme
Response by University of Auckland to Ellen Veronica on .
Awaiting classification.
Dear Ellen,
I refer to your email of 20 September 2022. The University’s response
follows.
“Currently, students wishing to enter the MBChB...
New Zealand Pandemic Risk Profile
Response by Department of the Prime Minister and Cabinet to Harold on .
Successful.
Kia Ora Harold
Please find the attached correspondence from the Department of the Prime
Minister and Cabinet.
Ngā mihi,
Ministerial...
Arrow Venlafaxine needs to come back under NZ funding.
Response by Pharmaceutical Management Agency to VICKI CAREY on .
Partially successful.
Kia ora Vicki
Thank you for your enquiry. You have asked why the Arrow-Venlafaxine XR
and Efexor XR brands were removed when it was doing good f...
22 - ADHD Research Funding, Prioritisation, and Equity Gaps
Response by Health Research Council of New Zealand to Elspeth Baker-Vevers on .
Successful.
Kia ora,
Please find attached our response to your OIA request.
Ngā mihi nui,
OIA Requests
Health Research Council of New Zealand
Te Kaunihera Ran...